Cargando…
Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy
Precise drug delivery to tumors with low system toxicity is one of the most important and challenging tasks for pharmaceutical researchers. Despite progress in the field of nanotherapeutics, the use of artificially synthesized nanocarriers still faces several challenges, including rapid clearance fr...
Autores principales: | Huang, Yukun, Gao, Xiaoling, Chen, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985693/ https://www.ncbi.nlm.nih.gov/pubmed/29872618 http://dx.doi.org/10.1016/j.apsb.2017.12.001 |
Ejemplares similares
-
Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy
por: Seidu, Theodora Amanda, et al.
Publicado: (2022) -
Emerging transporter-targeted nanoparticulate drug delivery systems
por: Su, Hongyan, et al.
Publicado: (2019) -
Nanoparticulate systems for polynucleotide delivery
por: Basarkar, Ashwin, et al.
Publicado: (2007) -
Developing micro-/nanoparticulate drug delivery systems using “design of experiments”
por: Singh, Bhupinder, et al.
Publicado: (2011) -
Nanoparticulate drug delivery systems for the treatment of neglected
tropical protozoan diseases
por: Volpedo, Greta, et al.
Publicado: (2019)